Swedish Cancer Society radiation therapy research investigation

被引:13
作者
Mattsson, S
Brahme, A
Carlsson, J
Denekamp, J
Forssell-Aronsson, E
Hellström, M
Johansson, KA
Kjellén, E
Littbrand, B
Nordenskjöld, B
Stenerlöw, B
Turesson, I
Zackrisson, B
Glimelius, B
机构
[1] Malmo Univ Hosp, Dept Radiat Phys, Malmo, Sweden
[2] Karolinska Inst, Dept Med Radiat Phys, Stockholm, Sweden
[3] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
[4] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[5] Umea Univ, Dept Oncol, Umea, Sweden
[6] Gothenburg Univ, Dept Radiat Phys, S-41124 Gothenburg, Sweden
[7] Gothenburg Univ, Dept Diagnost Radiol, S-41124 Gothenburg, Sweden
[8] Univ Hosp, Dept Oncol, Lund, Sweden
[9] Univ Hosp, Dept Oncol, Linkoping, Sweden
关键词
D O I
10.1080/028418602321028193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In an investigation by the Swedish Cancer Society, the present status, critical issues and future aspects and prospects were described by an expert group for each of nine major areas of radiation research. A summary of the investigation is presented in this report. A more extensive summary (in Swedish) can be found at www.Cancerfonden.se, It is concluded that radiation therapy plays an increasingly important role in curative and palliative tumour treatment and presents a considerable challenge to research. Several suggestions are made that could improve the possibilities for high-quality radiation therapy research in Sweden.
引用
收藏
页码:596 / 603
页数:8
相关论文
共 24 条
[1]   Radiation therapy through activation of stable nuclides [J].
Carlsson, J ;
Forssell-Aronsson, E ;
Glimelius, B .
ACTA ONCOLOGICA, 2002, 41 (7-8) :629-634
[2]   Therapy with radiopharmaceuticals [J].
Carlsson, J ;
Forssell-Aronsson, E ;
Gliemlius, B ;
Mattson, S .
ACTA ONCOLOGICA, 2002, 41 (7-8) :623-628
[3]  
*CEC COMM EUR COMM, 1991, 381 CANMED CEC COMM
[4]   Radiation oncology - Linking technology and biology in the treatment of cancer [J].
Coleman, CN .
ACTA ONCOLOGICA, 2002, 41 (01) :6-13
[5]   An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer [J].
Foroudi, F ;
Tyldesley, SR ;
Walker, H ;
Mackillop, WJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05) :1240-1253
[6]   Medical imaging for improved tumour characterization, delineation and treatment verification [J].
Forsell-Aronsson, E ;
Kjellén, E ;
Mattsson, S ;
Hellström, M .
ACTA ONCOLOGICA, 2002, 41 (7-8) :604-614
[7]  
Frodin JE, 1996, ACTA ONCOL, V35, P967
[8]   Interactions between chemotherapy, endocrine therapy and radiation [J].
Glimelius, B ;
Nordenskjöld, B ;
Kjellén, E ;
Zackrisson, B .
ACTA ONCOLOGICA, 2002, 41 (7-8) :635-638
[9]   The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types -: Summary and conclusions [J].
Glimelius, B ;
Bergh, J ;
Brandt, L ;
Brorsson, B ;
Gunnars, B ;
Hafström, L ;
Haglund, U ;
Högberg, T ;
Janunger, KG ;
Jönsson, PE ;
Karlsson, G ;
Kimby, E ;
Lamnevik, G ;
Nilsson, S ;
Permert, J ;
Ragnhammar, P ;
Sörenson, S ;
Nygren, P .
ACTA ONCOLOGICA, 2001, 40 (2-3) :135-154
[10]   Technology, biology and traffic [J].
Hellman, S .
ACTA ONCOLOGICA, 2001, 40 (06) :679-681